In this episode, Stefan Lutzmayer, from IQVIA’s EMEA Thought Leadership team, speaks with Özgür Tuncer, CEO & Executive Director of Stablepharma, about the growing complexity of the pharmaceutical cold chain and how innovation could make it more resilient, sustainable, and accessible. IQVIA’s EMEA Thought Leadership team analyses major trends shaping the pharmaceutical market and their implications for healthcare systems and companies across the region. You’ll hear about: •Why “keeping ...
All content for The IQVIA Podcast is the property of IQVIA and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, Stefan Lutzmayer, from IQVIA’s EMEA Thought Leadership team, speaks with Özgür Tuncer, CEO & Executive Director of Stablepharma, about the growing complexity of the pharmaceutical cold chain and how innovation could make it more resilient, sustainable, and accessible. IQVIA’s EMEA Thought Leadership team analyses major trends shaping the pharmaceutical market and their implications for healthcare systems and companies across the region. You’ll hear about: •Why “keeping ...
Special Episode | Recording with BioSpace: Understanding the FDA’s AI Guidance in Pharmacovigilance
The IQVIA Podcast
25 minutes
1 month ago
Special Episode | Recording with BioSpace: Understanding the FDA’s AI Guidance in Pharmacovigilance
In this episode, BioSpace’s head of insights Lori Ellis discusses the FDA’s first draft guidance for AI in drug development, published in January 2025, with Archana Hegde, Senior Director, PV systems and innovations at IQVIA.
The IQVIA Podcast
In this episode, Stefan Lutzmayer, from IQVIA’s EMEA Thought Leadership team, speaks with Özgür Tuncer, CEO & Executive Director of Stablepharma, about the growing complexity of the pharmaceutical cold chain and how innovation could make it more resilient, sustainable, and accessible. IQVIA’s EMEA Thought Leadership team analyses major trends shaping the pharmaceutical market and their implications for healthcare systems and companies across the region. You’ll hear about: •Why “keeping ...
